1,047
Views
6
CrossRef citations to date
0
Altmetric
Review Articles

Flavonoids for depression and anxiety: a systematic review and meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Amsterdam, J. D., J. Shults, I. Soeller, J. J. Mao, K. Rockwell, and A. B. Newberg. 2012. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: An exploratory study. Alternative Therapies in Health and Medical 18 (5):44–9.
  • Atteritano, M., S. Mazzaferro, A. Bitto, M. L. Cannata, R. D’Anna, F. Squadrito, I. Macri, A. Frisina, N. Frisina, and G. Bagnato. 2014. Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: A 2-year randomized, double-blind, controlled study. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 25 (3):1123–9. doi: 10.1007/s00198-013-2512-5.
  • Barfoot, K. L., R. Forster, and D. J. Lamport. 2021. Mental health in new mothers: A randomised controlled study into the effects of dietary flavonoids on mood and perceived quality of life. Nutrients 13 (7):2383. doi: 10.3390/nu13072383.
  • Begg, C. B, and M. Mazumdar. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (4):1088–101. doi: 10.2307/2533446.
  • Cao, L. H., J. Y. Qiao, H. Y. Huang, X. Y. Fang, R. Zhang, M. S. Miao, and X. M. Li. 2019. PI3K-AKT signaling activation and icariin: The potential effects on the perimenopausal depression-like rat model. Molecules 24 (20):3700. doi: 10.3390/molecules24203700.
  • Carazzone, C., D. Mascherpa, G. Gazzani, and A. Papetti. 2013. Identification of phenolic constituents in red chicory salads (Cichorium intybus) by high-performance liquid chromatography with diode array detection and electrospray ionisation tandem mass spectrometry. Food Chemistry 138 (2–3):1062–71. doi: 10.1016/j.foodchem.2012.11.060.
  • Casini, M. L., G. Marelli, E. Papaleo, A. Ferrari, F. D’Ambrosio, and V. Unfer. 2006. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: A randomized, double-blind, crossover, placebo-controlled study. Fertility and Sterility 85 (4):972–8. doi: 10.1016/j.fertnstert.2005.09.048.
  • Cassidy, A., É. O’Reilly, C. Kay, L. Sampson, M. Franz, J. P. Forman, G. Curhan, and E. Rimm. 2011. Habitual intake of flavonoid subclasses and incident hypertension in adults. The American Journal of Clinical Nutrition 93 (2):338–47. doi: 10.3945/ajcn.110.006783.
  • Chen, Z. Y., D. Jing, K. G. Bath, A. Ieraci, T. Khan, C. J. Siao, D. G. Herrera, M. Toth, C. Yang, B. S. McEwen, et al. 2006. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science (New York, N.Y.) 314 (5796):140–3. doi: 10.1126/science.1129663.
  • Cox, K. H. M., D. J. White, A. Pipingas, K. Poorun, and A. Scholey. 2020. Further evidence of benefits to mood and working memory from lipidated curcumin in healthy older people: A 12-week, double-Blind, placebo-controlled, partial replication study. Nutrients 12 (6):1678. doi: 10.3390/nu12061678.
  • Crozier, A., I. B. Jaganath, and M. N. Clifford. 2009. Dietary phenolics: Chemistry, bioavailability and effects on health. Natural Product Reports 26 (8):1001–43. doi: 10.1039/b802662a.
  • de Sousa-Munoz, R. L, and R. G. Filizola. 2009. Efficacy of soy isoflavones for depressive symptoms of the climacteric syndrome. Maturitas 63 (1):89–93. doi: 10.1016/j.maturitas.2009.02.008.
  • Duivis, H. E., N. Vogelzangs, N. Kupper, P. de Jonge, and B. W. Penninx. 2013. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: Findings from the Netherlands study of depression and anxiety (NESDA). Psychoneuroendocrinology 38 (9):1573–85. doi: 10.1016/j.psyneuen.2013.01.002.
  • Egger, M., D. Smith, M. Schneider, and C. Minder. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research ed.) 315 (7109):629–34. doi: 10.1136/bmj.315.7109.629.
  • Fang, H., S. Tu, J. Sheng, and A. Shao. 2019. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. Journal of Cellular and Molecular Medicine 23 (4):2324–32. doi: 10.1111/jcmm.14170.
  • Fisk, J., S. Khalid, S. A. Reynolds, and C. M. Williams. 2020. Effect of 4 weeks daily wild blueberry supplementation on symptoms of depression in adolescents. British Journal of Nutrition 124 (2):181–8. doi: 10.1017/S0007114520000926.
  • Fox, M. E, and M. K. Lobo. 2019. The molecular and cellular mechanisms of depression: A focus on reward circuitry. Molecular Psychiatry 24 (12):1798–815. doi: 10.1038/s41380-019-0415-3.
  • Gao, X., A. Cassidy, M. A. Schwarzschild, E. B. Rimm, and A. Ascherio. 2012. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology 78 (15):1138–45. doi: 10.1212/WNL.0b013e31824f7fc4.
  • Gonul, A. S., F. Akdeniz, F. Taneli, O. Donat, C. Eker, and S. Vahip. 2005. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 255 (6):381–6. doi: 10.1007/s00406-005-0578-6.
  • Guo, X. F., Y. Ruan, Z. H. Li, and D. Li. 2019. Flavonoid subclasses and type 2 diabetes mellitus risk: A meta-analysis of prospective cohort studies. Critical Reviews in Food Science and Nutrition 59 (17):2850–62. doi: 10.1080/10408398.2018.1476964.
  • Heim, C., D. J. Newport, T. Mletzko, A. H. Miller, and C. B. Nemeroff. 2008. The link between childhood trauma and depression: Insights from HPA axis studies in humans. Psychoneuroendocrinology 33 (6):693–710. doi: 10.1016/j.psyneuen.2008.03.008.
  • Higgins, J. P. T, and S. Green. 2017. Cochrane handbook for systematic reviews of interventions Version 5.1. 0 (updated March 2011). The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org.
  • Hirose, A., M. Terauchi, M. Akiyoshi, Y. Owa, K. Kato, and T. Kubota. 2016. Low-dose isoflavone aglycone alleviates psychological symptoms of menopause in Japanese women: A randomized, double-blind, placebo-controlled study. Archives of Gynecology and Obstetrics 293 (3):609–15. doi: 10.1007/s00404-015-3849-0.
  • Hosseinzadeh, E., A. Hassanzadeh, F. Marofi, M. R. Alivand, and S. Solali. 2020. Flavonoid-based cancer therapy: An updated review. Anti-Cancer Agents in Medicinal Chemistry 20 (12):1398–414. doi: 10.2174/1871520620666200423071759.
  • Ingersoll, G. L., A. Wasilewski, M. Haller, K. Pandya, J. Bennett, H. He, C. Hoffmire, and C. Berry. 2010. Effect of concord grape juice on chemotherapy-induced nausea and vomiting: Results of a pilot study. Oncology Nursing Forum 37 (2):213–21. doi: 10.1188/10.ONF.213-221.
  • Jorm, A. F., S. B. Patten, T. S. Brugha, and R. Mojtabai. 2017. Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries. World Psychiatry: Official Journal of the World Psychiatric Association (WPA) 16 (1):90–9. doi: 10.1002/wps.20388.
  • Jou, H. J., P. Y. Ling, and S. C. Wu. 2005. Comparison of 70 mg and 35 mg isoflavone soya supplement for menopause symptoms. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 90 (2):159–60. doi: 10.1016/j.ijgo.2005.03.011.
  • Juruena, M. F., F. Eror, A. J. Cleare, and A. H. Young. 2020. The role of early life stress in HPA axis and anxiety. Advances in Experimental Medicine and Biology 1191:141–53. doi: 10.1007/978-981-32-9705-0_9.
  • Kawabata, K., Y. Kawai, and J. Terao. 2010. Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary-adrenal axis response in wistar rats. The Journal of Nutritional Biochemistry 21 (5):374–80. doi: 10.1016/j.jnutbio.2009.01.008.
  • Kessler, R. C. 2012. The costs of depression. The Psychiatric Clinics of North America 35 (1):1–14. doi: 10.1016/j.psc.2011.11.005.
  • Kim, J. L., J. Cho, S. Park, and E. C. Park. 2015. Depression symptom and professional mental health service use. BMC Psychiatry 15:261. doi: 10.1186/s12888-015-0646-z.
  • Ko, Y. H., S. K. Kim, S. Y. Lee, and C. G. Jang. 2020. Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression. Archives of Pharmacal Research 43 (11):1128–43. doi: 10.1007/s12272-020-01292-5.
  • Lee, B., M. Yeom, I. Shim, H. Lee, and D. H. Hahm. 2020. Protective Effects of quercetin on anxiety-like symptoms and neuroinflammation induced by lipopolysaccharide in rats. Evidence-Based Complementary and Alternative Medicine: eCAM 2020:4892415. doi: 10.1155/2020/4892415.
  • Lepine, J. P, and M. Briley. 2011. The increasing burden of depression. Neuropsychiatric Disease and Treatment 7 (Suppl 1):3–7. doi: 10.2147/NDT.S19617.
  • Li, M, and A. E. Hagerman. 2013. Interactions between plasma proteins and naturally occurring polyphenols. Current Drug Metabolism 14 (4):432–45. doi: 10.2174/1389200211314040006.
  • Lipovac, M., P. Chedraui, C. Gruenhut, A. Gocan, M. Stammler, and M. Imhof. 2010. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 65 (3):258–61. doi: 10.1016/j.maturitas.2009.10.014.
  • Lochmann, D, and T. Richardson. 2019. Selective serotonin reuptake inhibitors. Handbook of Experimental Pharmacology 250:135–44. doi: 10.1007/164_2018_172.
  • Maes, M., R. Yirmyia, J. Noraberg, S. Brene, J. Hibbeln, G. Perini, M. Kubera, P. Bob, B. Lerer, and M. Maj. 2009. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression. Metabolic Brain Disease 24 (1):27–53. doi: 10.1007/s11011-008-9118-1.
  • Mao, J. J., S. X. Xie, J. R. Keefe, I. Soeller, Q. S. Li, and J. D. Amsterdam. 2016. Long-term chamomile (matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 23 (14):1735–42. doi: 10.1016/j.phymed.2016.10.012.
  • Martinowich, K., H. Manji, and B. Lu. 2007. New insights into BDNF function in depression and anxiety. Nature Neuroscience 10 (9):1089–93. doi: 10.1038/nn1971.
  • Masella, R., D. Benedetto, R. Vari, C. Filesi, and C. Giovannini. 2005. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. The Journal of Nutritional Biochemistry 16 (10):577–86. doi: 10.1016/j.jnutbio.2005.05.013.
  • McCullough, M. L., J. J. Peterson, R. Patel, P. F. Jacques, R. Shah, and J. T. Dwyer. 2012. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. The American Journal of Clinical Nutrition 95 (2):454–64. doi: 10.3945/ajcn.111.016634.
  • Miret, M., J. L. Ayuso-Mateos, J. Sanchez-Moreno, and E. Vieta. 2013. Depressive disorders and suicide: Epidemiology, risk factors, and burden. Neuroscience and Biobehavioral Reviews 37 (10 Pt 1):2372–4. doi: 10.1016/j.neubiorev.2013.01.008.
  • Mouri, A., H. J. Lee, T. Mamiya, Y. Aoyama, Y. Matsumoto, H. Kubota, W. J. Huang, L. C. Chiou, and T. Nabeshima. 2020. Hispidulin attenuates the social withdrawal in isolated disrupted-in-schizophrenia-1 mutant and chronic phencyclidine-treated mice. British Journal of Pharmacology 177 (14):3210–24. doi: 10.1111/bph.15043.
  • Murrough, J. W., S. Yaqubi, S. Sayed, and D. S. Charney. 2015. Emerging drugs for the treatment of anxiety. Expert Opinion on Emerging Drugs 20 (3):393–406. doi: 10.1517/14728214.2015.1049996.
  • Nakajima, A, and Y. Ohizumi. 2019. Potential benefits of nobiletin, a citrus flavonoid, against alzheimer’s disease and parkinson’s disease. International Journal of Molecular Sciences 20 (14)3380. doi: 10.3390/ijms2014:.
  • Nemeroff, C. B. 2002. Recent advances in the neurobiology of depression. Psychopharmacology Bulletin 36 (Suppl 2):6–23.
  • Palta, P., L. J. Samuel, E. R. Miller, 3rd, and S. L. Szanton. 2014. Depression and oxidative stress: Results from a meta-analysis of observational studies. Psychosomatic Medicine 76 (1):12–9. doi: 10.1097/PSY.0000000000000009.
  • Park, M., J. Choi, and H. J. Lee. 2020. Flavonoid-rich orange juice intake and altered gut microbiome in young adults with depressive symptom: A randomized controlled study. Nutrients 12 (6)1815. doi: 10.3390/nu1206:.
  • Peluso, I., C. Miglio, G. Morabito, F. Ioannone, and M. Serafini. 2015. Flavonoids and immune function in human: A systematic review. Critical Reviews in Food Science and Nutrition 55 (3):383–95. doi: 10.1080/10408398.2012.656770.
  • Peng, G. J., J. S. Tian, X. X. Gao, Y. Z. Zhou, and X. M. Qin. 2015. Research on the pathological mechanism and drug treatment mechanism of depression. Current Neuropharmacology 13 (4):514–23. doi: 10.2174/1570159x1304150831120428.
  • Rashno, M., S. Ghaderi, A. Nesari, L. Khorsandi, Y. Farbood, and A. Sarkaki. 2020. Chrysin attenuates traumatic brain injury-induced recognition memory decline, and anxiety/depression-like behaviors in rats: Insights into underlying mechanisms. Psychopharmacology ) 237 (6):1607–19. doi: 10.1007/s00213-020-05482-3.
  • Ross, J. A, and C. M. Kasum. 2002. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annual Review of Nutrition 22:19–34. doi: 10.1146/annurev.nutr.22.111401.144957.
  • Rothmore, J. 2020. Antidepressant-induced sexual dysfunction. The Medical Journal of Australia 212 (7):329–34. doi: 10.5694/mja2.50522.
  • Rui, W., S. Li, H. Xiao, M. Xiao, and J. Shi. 2020. Baicalein attenuates neuroinflammation by inhibiting NLRP3/caspase-1/GSDMD pathway in MPTP induced mice model of parkinson’s disease. International Journal of Neuropsychopharmacology 23 (11):762–73. Epub ahead of print. doi: 10.1093/ijnp/pyaa060.
  • Samad, N., A. Saleem, F. Yasmin, and M. A. Shehzad. 2018. Quercetin protects against stress-induced anxiety- and depression-like behavior and improves memory in male mice. Physiological Research 67 (5):795–808. doi: 10.33549/physiolres.933776.
  • Sartori, S. B, and N. Singewald. 2019. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology & Therapeutics 204:107402. doi: 10.1016/j.pharmthera.2019.107402.
  • Sawamoto, A., S. Okuyama, K. Yamamoto, Y. Amakura, M. Yoshimura, M. Nakajima, and Y. Furukawa. 2016. 3,5,6,7,8,3’,4’-Heptamethoxyflavone, a citrus flavonoid, ameliorates corticosterone-induced depression-like behavior and restores brain-derived neurotrophic factor expression, neurogenesis, and neuroplasticity in the hippocampus. Molecules (Basel, Switzerland) 21 (4):541. doi: 10.3390/molecules21040541.
  • Shafiee, M., M. Tayefi, S. M. Hassanian, Z. Ghaneifar, M. R. Parizadeh, A. Avan, F. Rahmani, Z. Khorasanchi, M. R. Azarpajouh, H. Safarian, et al. 2017. Depression and anxiety symptoms are associated with white blood cell count and red cell distribution width: A sex-stratified analysis in a population-based study. Psychoneuroendocrinology 84:101–8. doi: 10.1016/j.psyneuen.2017.06.021.
  • Smith, K. 2014. Mental health: A world of depression. Nature 515 (7526):181. doi: 10.1038/515180a.
  • Solem, S., R. Hagen, C. E. Wang, O. Hjemdal, K. Waterloo, M. Eisemann, and M. Halvorsen. 2017. Metacognitions and mindful attention awareness in depression: A comparison of currently depressed, previously depressed and never depressed individuals. Clinical Psychology & Psychotherapy 24 (1):94–102. doi: 10.1002/cpp.1983.
  • Song, X., B. Liu, L. Cui, B. Zhou, W. Liu, F. Xu, T. Hayashi, S. Hattori, Y. Ushiki-Kaku, S. I. Tashiro, et al. 2017. Silibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus. Physiology & Behavior 179:487–93. doi: 10.1016/j.physbeh.2017.07.023.
  • Stokes, P. E. 1995. The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 5:77–82. doi: 10.1016/0924-977X(95)00039-R.
  • Tyrer, P. 2001. The case for cothymia: Mixed anxiety and depression as a single diagnosis. The British Journal of Psychiatry: The Journal of Mental Science 179:191–3. doi: 10.1192/bjp.179.3.191.
  • Wedick, N. M., A. Pan, A. Cassidy, E. B. Rimm, L. Sampson, B. Rosner, W. Willett, F. B. Hu, Q. Sun, and R. M. van Dam. 2012. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. The American Journal of Clinical Nutrition 95 (4):925–33. doi: 10.3945/ajcn.111.028894.
  • Yang, M., J. Li, C. Zhao, H. Xiao, X. Fang, and J. Zheng. 2021. LC-Q-TOF-MS/MS detection of food flavonoids: Principle, methodology, and applications. Critical Reviews in Food Science and Nutrition:1–21. doi: 10.1080/10408398.2021.1993128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.